$AOS

A.O. Smith (AOS) Q3 2026 Earnings Call Transcript

A. O. Smith (AOS) announced a deal to sell 81% of its China business to CPE for $400M, retaining a 19% stake. Q3 2026 sales were $941M, flat year-over-year, with EPS at $0.93. North America saw 3% growth, while China sales dropped 17%. The company plans to use proceeds for share buybacks and faces rising input costs, implementing price increases to offset them.

Original reporting
Published Oct 29, 2026, 8:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
A.O. Smith (AOS) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AOSNeutralMed
01

Why it matters

The definitive China divestment agreement changes the company’s geographic risk profile and cash allocation plan (repatriation for share repurchases). Separately, management is responding to steel and freight inflation with pricing actions and cost offsets, which affects margin trajectory into year-end and beyond.

02

Market read

Traders can update expectations for AOS’s China earnings contribution, cash generation, and margin path based on the deal structure, repatriation plan, and December pricing increase.

03

What to watch

Near-term shipment delays from the Groveport, Ohio manufacturing cessation and transfer could pressure volumes and working capital before the benefits of footprint optimization show up.

Relevance 8/10Novelty 7/10Timing: deal close targeted for first half of 2027; price increase effective December

Background

A.O. Smith completed a strategic assessment begun in July of last year and is restructuring its China exposure while reporting Q3 results and cost pressures.

Company-level read

Ticker impact

$AOSNeutralMedium confidence
Context

A.O. Smith disclosed a definitive agreement to sell 81% of its China business to CPE, retain 19%, and close in 1H 2027.

Expected impact

Likely mixed reaction, with upside from monetizing China and repatriation offset by uncertainty around China demand disruption and margin pressure from steel and freight.

Evidence & confidence

The article provides concrete transaction structure (81%/19%, $400M valuation, licensing, expected total value >$500M, repatriation and buybacks) and operational cost actions (steel and freight double-digit increases, price increase up to 9.5% effective December), which can re-rate cash flow and margin outlook, but China volume weakness and near-term manufacturing transition delays add downside risk.

Market effects

Highlights ongoing cost inflation (steel, freight) and pricing pass-through dynamics for residential/commercial water heating and related components.

China segment weakness (local currency sales down 17%) underscores demand softness and execution risk during strategic assessment transitions.

Transaction and repatriation/buyback plans may influence broader industrial cash-flow sentiment, but impact is primarily company-specific.

Counterpoint

The China sale could be interpreted as an admission that the business cannot compete in the current market, making the retained 19% less of a growth lever than a risk hedge.

Key entities

  • A.O. Smith

    US-listed manufacturer reporting Q3 results and announcing a definitive agreement to sell 81% of its China business to CPE.

  • CPE

    Alternative asset manager that will acquire 81% of A.O. Smith’s China business under the definitive agreement.

Related articles

$AOSMedAI 8/10

A.O. Smith Corporation Q3 2026 Earnings Call Summary

A. O. Smith is divesting 81% of its China business, retaining a 19% stake and licensing royalties. North America saw growth in boilers and water treatment, offsetting a 1% decline in water heater sales. The company plans a 9.5% price increase to counter rising costs. Full-year 2026 guidance projects 4% sales growth and adjusted EPS of $3.42-$3.52 for its core business. Management expects higher cost run rates and prioritizes share repurchases with proceeds from the China transaction.

$AOSMed

A.O. Smith 3Q 2026: Revenue $940.5M, EPS $0.93— 10-Q Summary

A. O. Smith reported Q3 2026 revenue of $940.5M, down 0.2% YoY, and net income of $126.3M, down 4.3%. EPS was $0.93, a 1.1% decrease. North American sales grew 3%, while Rest of World sales fell 7%. The company agreed to sell an 81% stake in its China business for $400M, with a planned 2027 close. Steel and freight cost increases led to announced price hikes of up to 9.5% in North America.

$AOSMedAI 8/10

A.O. Smith Q3 2026 slides: China exit to boost margins, sharpen focus

A. O. Smith (NYSE:AOS) reported Q3 2026 sales of $941M, down 1% YoY, with adjusted EPS of $0.93, beating estimates. The company announced a $400M deal to sell 81% of its China business, expecting to improve margins by 200 basis points. North American sales grew 3%, while international sales fell 7%. The stock rose 1.46% post-announcement. Management plans to use proceeds for share repurchases. Full-year guidance was maintained, with adjusted EPS projected at $3.42-$3.52.

$AOSHighAI 8/10

A.O. Smith (NYSE:AOS) misses Q3 2026 sales expectations

A.O. Smith (AOS) reported Q3 2026 revenue of $940.5M, missing estimates by 2.1% YoY. Adjusted EPS of $0.93 beat estimates by 3.9%. Operating margin was 18.6%, stable YoY. Free cash flow margin declined to 17.3% from 25.5% YoY. The company announced a deal to sell 81% of its China business to CPE, retaining 19%.